Suchergebnisse - "Joseph, Magdalene"

PubPharm (17)

1

Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines

enthalten in: bioRxiv.org | 2023

von Monin-Aldama, L. | Laing, A. | Muñoz-Ruiz, M. | +38

2

A consensus Covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis

enthalten in: bioRxiv.org | 2022

von Laing, A. | Lorenc, A. | Del Molino Del Barrio, I. | +45

3

Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2022

von Joseph, M. | Wu, Y. | Dannebaum, R. | +38

4

A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer

enthalten in: Nature cancer | 2022

von Wu, Y. | Biswas, D. | Usaite, I. | +118

CommentIn: Nat Cancer. 2022 Jun;3(6):657-658. - PMID 35764741

5

Is there a role for physical activity when treating patients with cancer with immune checkpoint inhibitors? Protocol for a scoping review

enthalten in: BMJ open | 2021

von Chen, M. | Raj, R. | Fox, L. | +8

6

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer : interim analysis of a prospective observational study

enthalten in: The Lancet. Oncology | 2021

von Monin, L. | Laing, A. | Muñoz-Ruiz, M. | +41

CommentIn: Lancet Oncol. 2021 Jun;22(6):738-739. - PMID 34087120

7

Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant

enthalten in: Immunity | 2021

von Graham, C. | Seow, J. | Huettner, I. | +26

UpdateOf: bioRxiv. 2021 Feb 03;:. - PMID 33564766

8

Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS–CoV–2 Spike

enthalten in: bioRxiv.org | 2021

von Graham, C. | Seow, J. | Huettner, I. | +24

9

Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike

enthalten in: bioRxiv : the preprint server for biology | 2021

von Graham, C. | Seow, J. | Huettner, I. | +24

UpdateIn: Immunity. 2021 Jun 8;54(6):1276-1289.e6. - PMID 33836142

10

Author Correction : A dynamic COVID-19 immune signature includes associations with poor prognosis

enthalten in: Nature medicine | 2020

von Laing, A. | Lorenc, A. | Del Molino Del Barrio, I. | +47

ErratumFor: Nat Med. 2020 Oct;26(10):1623-1635. - PMID 32807934